238 related articles for article (PubMed ID: 15072113)
1. Adverse drug reactions and off-label prescribing for paediatric outpatients: a one-year survey of spontaneous reports in Sweden.
Ufer M; Kimland E; Bergman U
Pharmacoepidemiol Drug Saf; 2004 Mar; 13(3):147-52. PubMed ID: 15072113
[TBL] [Abstract][Full Text] [Related]
2. Paediatric adverse drug reactions reported in Sweden from 1987 to 2001.
Kimland E; Rane A; Ufer M; Panagiotidis G
Pharmacoepidemiol Drug Saf; 2005 Jul; 14(7):493-9. PubMed ID: 15918163
[TBL] [Abstract][Full Text] [Related]
3. Reported adverse drug reactions and their determinants in Dutch children outside the hospital.
Schirm E; Tobi H; van Puijenbroek EP; Monster-Simons MH; de Jong-van den Berg LT
Pharmacoepidemiol Drug Saf; 2004 Mar; 13(3):159-65. PubMed ID: 15072115
[TBL] [Abstract][Full Text] [Related]
4. Psychiatric adverse drug reactions reported during a 10-year period in the Swedish pediatric population.
Bygdell M; Brunlöf G; Wallerstedt SM; Kindblom JM
Pharmacoepidemiol Drug Saf; 2012 Jan; 21(1):79-86. PubMed ID: 22076661
[TBL] [Abstract][Full Text] [Related]
5. Spontaneously reported fatal suspected adverse drug reactions: a 10-year survey from Sweden.
Wester K; Jönsson A; Spigset O; Hägg S
Pharmacoepidemiol Drug Saf; 2007 Feb; 16(2):173-80. PubMed ID: 16739241
[TBL] [Abstract][Full Text] [Related]
6. Montelukast and psychiatric disorders in children.
Wallerstedt SM; Brunlöf G; Sundström A; Eriksson AL
Pharmacoepidemiol Drug Saf; 2009 Sep; 18(9):858-64. PubMed ID: 19551697
[TBL] [Abstract][Full Text] [Related]
7. Paediatric adverse drug reaction reporting: understanding and future directions.
Carleton BC; Smith MA; Gelin MN; Heathcote SC
Can J Clin Pharmacol; 2007; 14(1):e45-57. PubMed ID: 17297195
[TBL] [Abstract][Full Text] [Related]
8. Off-label prescribing in pediatric outpatients.
Palmaro A; Bissuel R; Renaud N; Durrieu G; Escourrou B; Oustric S; Montastruc JL; Lapeyre-Mestre M
Pediatrics; 2015 Jan; 135(1):49-58. PubMed ID: 25511119
[TBL] [Abstract][Full Text] [Related]
9. Widespread off-label prescribing of topical but not systemic drugs for 350,000 paediatric outpatients in Stockholm.
Ufer M; Rane A; Karlsson A; Kimland E; Bergman U
Eur J Clin Pharmacol; 2003 Mar; 58(11):779-83. PubMed ID: 12634986
[TBL] [Abstract][Full Text] [Related]
10. A survey of off-label prescribing for inpatients with mild intellectual disability and mental illness.
Haw C; Stubbs J
J Intellect Disabil Res; 2005 Nov; 49(Pt 11):858-64. PubMed ID: 16207284
[TBL] [Abstract][Full Text] [Related]
11. Characteristics and quality of adverse drug reaction reports by pharmacists in Norway.
Gedde-Dahl A; Harg P; Stenberg-Nilsen H; Buajordet M; Granas AG; Horn AM
Pharmacoepidemiol Drug Saf; 2007 Sep; 16(9):999-1005. PubMed ID: 17457794
[TBL] [Abstract][Full Text] [Related]
12. Spontaneous reporting of adverse drug reactions by nurses.
Bäckström M; Mjörndal T; Dahlqvist R
Pharmacoepidemiol Drug Saf; 2002 Dec; 11(8):647-50. PubMed ID: 12512239
[TBL] [Abstract][Full Text] [Related]
13. [Off-label use of psychotropic medications in pediatric wards: a prospective study].
Winterfeld U; Le Heuzey MF; Acquaviva E; Mouren MC; Brion F; Bourdon O
Arch Pediatr; 2009 Sep; 16(9):1252-60. PubMed ID: 19640689
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of adverse drug reactions with commonly prescribed drugs in different hospitals of Kathmandu valley.
Jha N; Bajracharya O; Namgyal T
Kathmandu Univ Med J (KUMJ); 2007; 5(4):504-10. PubMed ID: 18604084
[TBL] [Abstract][Full Text] [Related]
15. Nurses are increasingly involved in pharmacovigilance in Sweden.
Ulfvarson J; Mejyr S; Bergman U
Pharmacoepidemiol Drug Saf; 2007 May; 16(5):532-7. PubMed ID: 17072915
[TBL] [Abstract][Full Text] [Related]
16. Dissemination of information on potentially fatal adverse drug reactions for cancer drugs from 2000 to 2002: first results from the research on adverse drug events and reports project.
Ladewski LA; Belknap SM; Nebeker JR; Sartor O; Lyons EA; Kuzel TC; Tallman MS; Raisch DW; Auerbach AR; Schumock GT; Kwaan HC; Bennett CL
J Clin Oncol; 2003 Oct; 21(20):3859-66. PubMed ID: 14551305
[TBL] [Abstract][Full Text] [Related]
17. Changes in anticonvulsant prescribing for Australian children: implications for Quality Use of Medicines.
Cohen SA; Lawson JA; Graudins LV; Pearson SA; Gazarian M
J Paediatr Child Health; 2012 Jun; 48(6):490-5. PubMed ID: 22050665
[TBL] [Abstract][Full Text] [Related]
18. Under-reporting of serious adverse drug reactions in Sweden.
Bäckström M; Mjörndal T; Dahlqvist R
Pharmacoepidemiol Drug Saf; 2004 Jul; 13(7):483-7. PubMed ID: 15269932
[TBL] [Abstract][Full Text] [Related]
19. Drug, patient, and physician characteristics associated with off-label prescribing in primary care.
Eguale T; Buckeridge DL; Winslade NE; Benedetti A; Hanley JA; Tamblyn R
Arch Intern Med; 2012 May; 172(10):781-8. PubMed ID: 22507695
[TBL] [Abstract][Full Text] [Related]
20. Discrepancies in reported drug use in geriatric outpatients: relevance to adverse events and drug-drug interactions.
Tulner LR; Kuper IM; Frankfort SV; van Campen JP; Koks CH; Brandjes DP; Beijnen JH
Am J Geriatr Pharmacother; 2009 Apr; 7(2):93-104. PubMed ID: 19447362
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
